Search Results for: ACS MARKET Acute Coronary Syndrome
Articles
ACS MARKET - Acute Coronary Syndrome Market 2015-2025 November 7, 2016
Michela J. McMullan, PhD, GlobalData Analyst, reports that although the ACS market is set to grow at a CAGR of 4.6%, reaching $12.1B by 2025, the potential for the market to be even more lucrative exists, especially in the sizable lipid-targeting arena.
Novel Lipid-Altering Therapies Will Steer ACS Market Beyond $12 Billion August 11, 2016
The acute coronary syndrome (ACS) market is set to rise from $7.8 billion in 2015 to $12.1 billion by 2022,...Novel Lipid-Altering Therapies Will Steer ACS Market Beyond $12 Billion August 11, 2016
The acute coronary syndrome (ACS) market is set to rise from $7.8 billion in 2015 to $12.1 billion by 2022,...Branded Acute Coronary Syndrome Therapies to Grab Market Share From Generic Drugs Globally September 2, 2015
The acute coronary syndrome (ACS) therapeutics market consists of approximately 30 marketed branded drugs and hundreds of generics. While generic...ACS Treatment Market to More Than Triple From $12.3 Billion to $43.4 Billion August 4, 2014
The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary syndrome (ACS) treatment market to more...ACS Treatment Market to More Than Triple From $12.3 Billion to $43.4 Billion July 29, 2014
The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary syndrome (ACS) treatment market to more...Cardiovascular Disease Market: US to Lead Modest Growth; Electronic Cigarettes Could Be the Next Blockbuster December 11, 2013
The global market for Cardiovascular Disease (CVD) - composed of Heart Failure (HF), Myocardial Infarction (MI), and Acute Coronary Syndrome...FORMULATION FORUM - Application of Nano-Emulsion Technology to Address Unmet Medical Needs: A Case Study of Clopidogrel IV by 505(b)(2) Pathway May 4, 2020
Jim Huang, PhD, presents a case study on how the EmulSol technology produces stable, optically clear nano-emulsions without the use of organic solvents and with minimal use of surfactants using a high-pressure or microfluidic homogenization process.
NANOEMULSION FORMULATIONS - Nanoemulsion Formulations for Injection & Oral Administration October 2, 2014
Troy M. Harmon, MS, MBA, and Jingjun Huang, PhD, use Ascendia’s EmulSol technology to develop a novel oil-in-water nanoemulsion formulation of clopidogrel whereby the free-base form of clopidogrel has acceptable solubility in the oil phase, and is protected from chemical degradation.
